Selected article for: "antibody response and study objective"
Title: 2018 ACVIM Forum Research Abstract Program: Seattle, Washington, June 14 - 15, 2018
  • Document date: 2018_10_25
    • ID: 60ceejq1_140
    Snippet: The IDEXX SNAP Lepto provides a rapid in-clinic test for evidence of antibody response to Leptospira species in horses, with excellent specificity and high sensitivity with increasing titers. Leptospirosis associated abortion and acute renal disease often result in MAT titers of ≥ 6,400. This test kit may allow for prompt stall-side or field determination of Leptospirosis status in these cases. Bacterial and viral microbiotas often inhabit and .....
    Document: The IDEXX SNAP Lepto provides a rapid in-clinic test for evidence of antibody response to Leptospira species in horses, with excellent specificity and high sensitivity with increasing titers. Leptospirosis associated abortion and acute renal disease often result in MAT titers of ≥ 6,400. This test kit may allow for prompt stall-side or field determination of Leptospirosis status in these cases. Bacterial and viral microbiotas often inhabit and share the same microenvironments, however, interest in their potential contribution in promoting health or disease has only recently gained attention. The objective of this study was to characterize the nasal bacterial microbiota of healthy horses (control) and horses shedding equine herpes virus-1 (EHV-1) using next generation sequencing technology.

    Search related documents:
    Co phrase search for related documents
    • acute renal disease and study objective: 1
    • antibody response and attention gain: 1
    • antibody response and clinic test: 1
    • antibody response and disease health: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • antibody response and excellent specificity: 1, 2
    • antibody response and high sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
    • antibody response and increase titer: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antibody response and renal disease: 1, 2, 3
    • antibody response and study objective: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • antibody response and technology sequencing: 1, 2, 3
    • antibody response and technology sequencing generation: 1
    • antibody response and test kit: 1, 2, 3, 4
    • attention gain and study objective: 1
    • clinic test and disease health: 1, 2, 3